Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 Correlates of Serodiscordant Condomless Anal Intercourse Among Virologically Detectable HIV-Positive Young Men Who Have Sex with MenAIDS and Behavior.  22:3535-3539. 2018
2018 Enzymes of pyrimidine salvage pathways in intraerythrocytic Plasmodium falciparum.The International journal of biochemistry.  105:115-122. 2018
2018 The role of socio-behavioral factors in sub-protective tenofovir diphosphate (TFV-DP) levels among YMSM enrolled in two PrEP trials.Journal of Acquired Immune Deficiency Syndromes2018
2018 A cross-sectional study examining associations between substance use frequency, problematic use and STIs among youth living with HIV.Sexually Transmitted Infections.  94:304-308. 2018
2018 HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus VaccinationAIDS and Behavior.  22:1826-1834. 2018
2018 Tobacco Use and Sustained Viral Suppression in Youth Living with HIVAIDS and Behavior.  22:2018-2025. 2018
2018 In replyJAMA Pediatrics.  172:391-392. 2018
2018 Linking HIV-Negative Youth to Prevention Services in 12 U.S. Cities: Barriers and Facilitators to Implementing the HIV Prevention ContinuumJournal of Adolescent Health.  62:424-433. 2018
2018 Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis among Adolescent and Young Men Who Have Sex with Men in the United StatesClinical Infectious Diseases.  66:213-219. 2018
2018 Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults with Human Immunodeficiency Virus Infection Being Treated with Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled TrialClinical Infectious Diseases.  66:220-228. 2018
2018 HIV Continuum of Care for Youth in the United States.Journal of Acquired Immune Deficiency Syndromes.  77:110-117. 2018
2018 Partner Notification for Youth Living With HIV in 14 Cities in the United States.Journal of Acquired Immune Deficiency Syndromes.  77:46-52. 2018
2017 Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.JAMA Pediatrics.  171:1063-1071. 2017
2017 Implementation of an Integrated Approach to the National HIV/AIDS Strategy for Improving Human Immunodeficiency Virus Care for Youths.JAMA Pediatrics.  171:687-693. 2017
2017 Evaluating Testing Strategies for Identifying Youths With HIV Infection and Linking Youths to Biomedical and Other Prevention Services.JAMA Pediatrics.  171:532-537. 2017
2017 Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.Clinical Infectious Diseases.  64:317-325. 2017
2017 Strengthening and expanding the capacity of health worker education in Zambia.Pan African Medical Journal.  27:92. 2017
2016 Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.Antimicrobial Agents and Chemotherapy.  60:6692-6697. 2016
2016 An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM.Journal of Acquired Immune Deficiency Syndromes.  74:21-29. 2016
2016 Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.Journal of NeuroVirology.  22:218-230. 2016
2016 Sexual Risk Behavior Among Virologically Detectable Human Immunodeficiency Virus-Infected Young Men Who Have Sex With Men.JAMA Pediatrics.  170:125-131. 2016
2016 Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa.Journal of the International AIDS Society.  19:21107. 2016
2015 Factors Associated With Smoking Status among HIV-Positive Patients in Routine Clinical Care.Journal of AIDS and Clinical Research.  6. 2015
2015 Mitochondrial DNA diversity in the African American population.DNA Sequence.  26:445-451. 2015
2015 Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.Journal of Acquired Immune Deficiency Syndromes.  69:52-60. 2015
2015 Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States.Journal of Acquired Immune Deficiency Syndromes.  68:169-177. 2015
2015 How we implemented an analytical support clinic to strengthen student research capacity in ZambiaMedical Teacher.  37:635-640. 2015
2014 Mitochondrial DNA variation and virologic and immunological HIV outcomes in African Americans.AIDS.  28:1871-1878. 2014
2014 How we implemented an analytic support clinic to strengthen student research capacity in ZambiaMedical Teacher.  1:1-6. 2014
2014 KIR2DS4 promotes HIV-1 pathogenesis: new evidence from analyses of immunogenetic data and natural killer cell function.PLoS ONE.  9:e99353. 2014
2014 Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate.Antiviral Therapy.  19:613-618. 2014
2013 Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents.Human Immunology.  74:1696-1700. 2013
2013 Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?Antimicrobial Agents and Chemotherapy.  57:5619-5628. 2013
2013 Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women.Clinical Infectious Diseases.  57:735-744. 2013
2013 Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States.Sexually Transmitted Diseases.  40:715-720. 2013
2013 Comprehension of a simplified assent form in a vaccine trial for adolescents.Journal of Medical Ethics.  39:410-412. 2013
2013 Body condition scoring for Laboratory ZebrafishAnimal Technology and Welfare.  12:1-7. 2013
2013 The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men.Journal of Acquired Immune Deficiency Syndromes.  62:447-456. 2013
2013 Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.AIDS Research and Human Retroviruses.  29:493-500. 2013
2013 Incidence of sexually transmitted infections in HIV-infected and HIV-uninfected adolescents in the USA.International Journal of STD and AIDS.  24:123-127. 2013
2013 Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein.Frontiers in Genetics.  4:234. 2013
2013 Oral Lesions: Poor Markers of Virologic Failure in HIV-Infected Patients on Antiretroviral TherapyISRN Infectious Diseases.  2013:1-7. 2013
2012 Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) study.Journal of Acquired Immune Deficiency Syndromes.  61:499-506. 2012
2012 Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents.Journal of Reproductive Immunology.  96:84-89. 2012
2012 Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.Journal of Acquired Immune Deficiency Syndromes.  61:390-399. 2012
2012 Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.Journal of Clinical Endocrinology and Metabolism.  97:4004-4013. 2012
2012 Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.Clinical Infectious Diseases.  55:461-468. 2012
2012 Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents.Sexually Transmitted Diseases.  39:300-305. 2012
2012 Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-na├»ve behaviorally HIV-infected youth.AIDS patient care.  26:193-196. 2012
2012 Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial.Clinical Infectious Diseases.  54:1013-1025. 2012
2012 Aspects of larval rearing.ILAR news.  53:169-178. 2012
2012 Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females.PLoS ONE.  7:e30736. 2012
2011 Prevalence, incidence, and recurrence of oral lesions among HIV-infected patients on HAART in Alabama: a two-year longitudinal study.Southern Medical Journal.  104:561-566. 2011
2011 Sex ratio bias and embryo production in Zebrafish housed in 10 litre aquariaAnimal Technology and Welfare.  10:146-147. 2011
2011 The Zambian HIV Nurse practitioner diploma program: Preliminary outcomes from first cohort of Zambian NursesInternational Journal of Nursing Education Scholarship.  8. 2011
2011 Identification of three immunologic correlates for HIV type 1 pathogenesis in youth.AIDS Research and Human Retroviruses.  27:639-646. 2011
2011 Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens.Journal of Acquired Immune Deficiency Syndromes.  56:325-332. 2011
2011 The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans.Human Immunology.  72:312-318. 2011
2011 Contemporary profile of oral manifestations of HIV/AIDS and associated risk factors in a Southeastern US clinic.Journal of Public Health Dentistry.  71:257-264. 2011
2011 Hormonal contraceptive use and response to antiretroviral therapy among adolescent femalesHIV and AIDS Review.  10:65-69. 2011
2010 Association between Anemia and Aflatoxin B-1 Biomarker Levels among Pregnant Women in Kumasi, GhanaAmerican Journal of Tropical Medicine and Hygiene.  83:1077-1083. 2010
2010 Interleukin-10 (IL-10) pathway: genetic variants and outcomes of HIV-1 infection in African American adolescents.PLoS ONE.  5:e13384. 2010
2010 The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.BMC Infectious Diseases.  10:295. 2010
2010 Epidemiology of HIV infection and risk in adolescents and youth.Journal of Acquired Immune Deficiency Syndromes.  54 Suppl 1:S5-S6. 2010
2010 Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United States.Pediatric Infectious Disease Journal.  29:530-534. 2010
2010 Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.Journal of Virology.  84:2610-2617. 2010
2010 Association between birth outcomes and aflatoxin B1 biomarker blood levels in pregnant women in Kumasi, Ghana.Tropical Medicine and International Health.  15:160-167. 2010
2010 Demographic profiles of newly acquired HIV infections among adolescents and young adults in the U.S.Journal of Adolescent Health.  46:93-96. 2010
2010 Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021.Clinical Infectious Diseases.  50:106-114. 2010
2009 Aspects of Zebrafish husbandry - Water quality control and system maintenanceAnimal Technology and Welfare.  8. 2009
2009 Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: analyses of the reaching for excellence in adolescent care and health (REACH) project.Archives of Pediatrics and Adolescent Medicine.  163:1100-1105. 2009
2009 Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth.Human Genetics.  126:685-696. 2009
2009 Short-cycle therapy in adolescents after continuous therapy with established viral suppression: the impact on viral load suppression.AIDS Research and Human Retroviruses.  25:555-561. 2009
2009 Host genetics and HIV-1 viral load set-point in African-Americans.AIDS.  23:673-677. 2009
2008 Immunogenetic correlates of Neisseria gonorrhoeae infection in adolescents.Sexually Transmitted Diseases.  35:656-661. 2008
2008 Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.Antimicrobial Agents and Chemotherapy.  52:631-637. 2008
2008 Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads.Journal of Acquired Immune Deficiency Syndromes.  47:86-92. 2008
2007 Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.AIDS.  21:2387-2397. 2007
2007 Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.Journal of the American Medical Association.  298:1888-1899. 2007
2007 HIV voluntary counseling and testing among injection drug users in south China: a study of a non-government organization based program.AIDS and Behavior.  11:778-788. 2007
2007 Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents.Cancer Epidemiology, Biomarkers and Prevention.  16:1626-1632. 2007
2007 CCL3L1 and CCL4L1: variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection.Genes and Immunity.  8:224-231. 2007
2007 Calibration and validation of an oral fluid-based sensitive/less-sensitive assay to distinguish recent from established HIV-1 infections.Journal of Clinical Laboratory Analysis.  21:40-45. 2007
2007 Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults.American Journal of Clinical Nutrition.  85:173-181. 2007
2006 Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study.Journal of Infectious Diseases.  194:1505-1509. 2006
2006 Cohort- and time-specific associations of CTLA4 genotypes with HIV-1 disease progression.AIDS.  20:1583-1590. 2006
2006 HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently.Journal of Immunology.  176:6130-6146. 2006
2006 Vitamin D status in adolescents and young adults with HIV infection.American Journal of Clinical Nutrition.  83:1135-1141. 2006
2006 Interleukin 18 and human immunodeficiency virus type I infection in adolescents and adults.Clinical and Experimental Immunology.  144:117-124. 2006
2006 Vitamins C and E in adolescents and young adults with HIV infection.American Journal of Clinical Nutrition.  83:870-879. 2006
2006 Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: week 60 results from the PACTG 381 cohort.AIDS Research and Human Retroviruses.  22:213-221. 2006
2006 Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients.AIDS.  20:353-360. 2006
2005 Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents.Clinical and Experimental Immunology.  142:548-554. 2005
2005 Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.Archives of Pediatrics and Adolescent Medicine.  159:764-770. 2005
2005 Plasma cytokines and oxidative damage in HIV-positive and HIV-negative adolescents and young adults: a protective role for IL-10?Free Radical Research.  39:859-864. 2005
2005 Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents.Journal of Infectious Diseases.  191:1084-1092. 2005
2005 CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides.AIDS.  19:241-250. 2005
2005 Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents.Journal of Acquired Immune Deficiency Syndromes.  38:180-190. 2005
2004 Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents.Journal of Infectious Diseases.  190:1723-1729. 2004
2004 HIV-infected US youth are at high risk of obesity and poor diet quality: a challenge for improving short- and long-term health outcomes.Journal of The American Dietetic Association.  104:1554-1560. 2004
2004 US youths in the early stages of HIV disease have low intakes of some micronutrients important for optimal immune function.Journal of The American Dietetic Association.  104:1095-1101. 2004
2004 Erratum: CD8+ CD38+ T cells but not HIV type 1 RNA viral load predict CD4+ cell loss in a predominantly minority female HIV+ adolescent population (AIDS Research and Human Retroviruses (2004) 22 (263-269))AIDS Research and Human Retroviruses.  20:575. 2004
2004 Cytokine and chemokine gene polymorphisms among ethnically diverse North Americans with HIV-1 infection.Journal of Acquired Immune Deficiency Syndromes.  35:446-454. 2004
2004 HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination.Hepatology.  39:978-988. 2004
2004 CD8+CD38+ T cells but not HIV type 1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV+ adolescent population.AIDS Research and Human Retroviruses.  20:263-269. 2004
2004 Tolerance and safety of different concentrations of chlorhexidine for peripartum vaginal and infant washes: HIVNET 025.Journal of Acquired Immune Deficiency Syndromes.  35:138-143. 2004
2003 T cell responses in HIV type 1-infected adolescent minorities share similar epitope specificities with whites despite significant differences in HLA class I alleles.AIDS Research and Human Retroviruses.  19:1017-1026. 2003
2003 Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities.Journal of Acquired Immune Deficiency Syndromes.  33:426-438. 2003
2003 CD4+ and CD8+ T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy-naive adolescents.AIDS Research and Human Retroviruses.  19:487-495. 2003
2003 Delayed onset of pubertal development in children and adolescents with perinatally acquired HIV infection.Journal of Acquired Immune Deficiency Syndromes.  33:56-65. 2003
2003 TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths.Clinical and Diagnostic Laboratory Immunology.  10:399-404. 2003
2003 The relationships between substance abuse, psychosocial variables, and natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents.AIDS Research and Human Retroviruses.  19:399-408. 2003
2003 Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circles.Clinical and Diagnostic Laboratory Immunology.  10:323-328. 2003
2003 Barriers to HAART adherence among human immunodeficiency virus-infected adolescents.Archives of Pediatrics and Adolescent Medicine.  157:249-255. 2003
2003 Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents.AIDS.  17:311-320. 2003
2002 Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents.AIDS.  16:2275-2284. 2002
2002 Increased proliferation within T lymphocyte subsets of HIV-infected adolescents.AIDS Research and Human Retroviruses.  18:1301-1310. 2002
2002 Barriers to HIV testing--where next?Lancet.  360:1186-1187. 2002
2002 Peripheral blood lymphocyte subsets in adolescents: a longitudinal analysis from the REACH project.Clinical and Diagnostic Laboratory Immunology.  9:959-965. 2002
2002 CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy.AIDS Research and Human Retroviruses.  18:403-412. 2002
2001 Douching practices among HIV infected and uninfected adolescents in the United States.Journal of Adolescent Health.  29:80-86. 2001
2001 HIV-related oral manifestations among adolescents in a multicenter cohort study.Journal of Adolescent Health.  29:109-114. 2001
2001 Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for Excellence in Adolescent Care and Health.Journal of Adolescent Health.  29:123-129. 2001
2001 Sexually transmitted infections among HIV infected and HIV uninfected high-risk youth in the REACH study. Reaching for Excellence in Adolescent Care and Health.Journal of Adolescent Health.  29:49-56. 2001
2001 The REACH (Reaching for Excellence in Adolescent Care and Health) project: study design, methods, and population profile.Journal of Adolescent Health.  29:8-18. 2001
2001 Natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents.AIDS Research and Human Retroviruses.  17:543-552. 2001
2001 Performance of antigens used in detecting delayed-type hypersensitivity in adolescents infected with the human immunodeficiency virus.Clinical and Diagnostic Laboratory Immunology.  8:273-278. 2001
2001 Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA.AIDS Care.  13:27-40. 2001
2000 The prevalence of anergy in human immunodeficiency virus-infected adolescents and the association of delayed-type hypersensitivity with subject characteristics.Journal of Adolescent Health.  27:384-390. 2000
2000 Marijuana use among HIV-positive and high-risk adolescents: a comparison of self-report through audio computer-assisted self-administered interviewing and urinalysis.American Journal of Epidemiology.  152:805-813. 2000
2000 Erratum: T-lymphocyte subsets in HIV-infected and high-risk HIV-uninfected adolescents: Retention of naive T lymphocytes in HIV-infected adolescents (Archives (2000) 154 (375-380))Archives of Pediatrics and Adolescent Medicine.  154:911. 2000
2000 Relationship of CD4+ T cell counts and HIV type 1 viral loads in untreated, infected adolescents. Adolescent Medicine HIV/AIDS Research Network.AIDS Research and Human Retroviruses.  16:959-963. 2000
2000 Seroprevalence and risk factors of hepatitis B, hepatitis C, and human cytomegalovirus among HIV-infected and high-risk uninfected adolescents: findings of the REACH Study. Adolescent Medicine HIV/AIDS Research Network.Sexually Transmitted Diseases.  27:296-303. 2000
2000 T-lymphocyte subsets in HIV-infected and high-risk HIV-uninfected adolescents: retention of naive T lymphocytes in HIV-infected adolescents. The Adolescent Medicine HIV/AIDS Research Network.Archives of Pediatrics and Adolescent Medicine.  154:375-380. 2000
2000 Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.Archives of Pediatrics and Adolescent Medicine.  154:127-134. 2000
2000 Pinworm (Enterobius vermicularis)Seminars in Pediatric Infectious Diseases.  11:252-256. 2000
1999 The adenosine transporter of Toxoplasma gondii. Identification by insertional mutagenesis, cloning, and recombinant expression.Journal of Biological Chemistry.  274:35255-35261. 1999
1999 Insertional tagging of at least two loci associated with resistance to adenine arabinoside in Toxoplasma gondii, and cloning of the adenosine kinase locus.Molecular and Biochemical Parasitology.  103:1-14. 1999
1999 Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents. Adolescent Medicine HIV/AIDS Research Network.AIDS.  13:1629-1635. 1999
1998 The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: design, methods, and selected characteristics of participants.Journal of Adolescent Health.  22:300-311. 1998
1997 Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum.Proceedings of the National Academy of Sciences.  94:13944-13949. 1997
1996 Molecular Characterization of Airport Malaria.Journal of Travel Medicine.  3:179-181. 1996
1996 Characterization of the delta-aminolevulinate synthase gene homologue in P. falciparum.Molecular and Biochemical Parasitology.  79:135-140. 1996
1996 Plasmodium falciparum: molecular characterization of multidrug-resistant Cambodian isolates.Experimental Parasitology.  82:97-103. 1996
1996 Characterization of the delta-aminolevulinate synthase gene homologue in P. falciparum.Molecular and Biochemical Parasitology.  75:271-276. 1996
1995 Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa.Molecular and Biochemical Parasitology.  74:157-166. 1995
1995 Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum.Molecular and Biochemical Parasitology.  69:135-138. 1995
1994 Respiratory distress caused by parasites.Pediatric Annals.  23:443-446. 1994
1994 Characterization of the pfmdr2 gene for Plasmodium falciparum.Molecular and Biochemical Parasitology.  63:311. 1994
1993 Characterization of the pfmdr2 gene for Plasmodium falciparum.Molecular and Biochemical Parasitology.  62:83-92. 1993
1993 Cross-reactivity between Stomatococcus mucilaginosus and latex agglutination for cryptococcal antigen.Lancet.  342:1119-1120. 1993
1993 The dihydroorotate dehydrogenase gene homologue of Plasmodium falciparum.Molecular and Biochemical Parasitology.  60:349-351. 1993
1993 Stage-specific transcripts of the Plasmodium falciparum pfmdr 1 gene.Molecular and Biochemical Parasitology.  57:203-211. 1993
1993 Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand.Molecular and Biochemical Parasitology.  57:151-160. 1993
1991 Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemia.Bone Marrow Transplantation.  8:143-145. 1991
1990 Scedosporium inflatum: clinical spectrum of a newly recognized pathogen.Journal of Infectious Diseases.  161:102-107. 1990
1989 Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum.Science.  244:1184-1186. 1989
1989 A concurrent epidemic of respiratory syncytial virus and echovirus 7 infections in an intensive care nursery.Pediatric Infectious Disease Journal.  8:24-29. 1989
1987 A technique for the administration of ribavirin to mechanically ventilated infants with severe respiratory syncytial virus infection.Critical Care Medicine.  15:1051-1054. 1987
1977 Variability of the lytic susceptibility of Neisseria gonorrhoeae to human sera.Journal of Immunology.  118:1843-1851. 1977
1977 Variations in buccal cell adhesion of Neisseria gonorrhoeae.Infection and Immunity.  16:709-711. 1977
1976 Increased antibiotic resistance of Neisseria gonorrhoeae in Korea.Antimicrobial Agents and Chemotherapy.  9:716-718. 1976

Chapter

Year Title Altmetric
2015 Giardiasis 2015
2015 Pinworm Infestations 2015
2012 Antiparasitic Agents.  1518-1545.e3. 2012

Teaching Activities

  • missing activity 2018
  • missing activity 2018
  • missing activity 2017
  • missing activity 2017
  • EPI699 - Project Research (Summer Term 2017) 2017
  • missing activity 2017
  • GHS604 - Infect Diseas of Glb Hlth Sign (Spring Term 2017) 2017
  • EPI699 - Project Research (Fall Term 2016) 2016
  • GHS600 - Fundamentals of Global Health (Summer Term 2016) 2016
  • GHS604 - Infect Diseas of Glb Hlth Sign (Spring Term 2016) 2016
  • PUH332 - Communicable Disease (Spring Term 2016) 2016
  • EPI799 - Dissertation Research (Fall Term 2015) 2015
  • missing activity 2015
  • missing activity 2015
  • EPI798 - Doctoral Directed Research (Summer Term 2015) 2015
  • missing activity 2015
  • missing activity 2015
  • missing activity 2015
  • EPI799 - Dissertation Research (Spring Term 2015) 2015
  • GHS600 - Fundamentals of Global Health (Spring Term 2015) 2015
  • missing activity 2014
  • missing activity 2014
  • EPI798 - Doctoral Directed Research (Summer Term 2014) 2014
  • GHS600 - Fundamentals of Global Health (Summer Term 2014) 2014
  • missing activity 2014
  • missing activity 2014
  • missing activity 2014
  • missing activity 2014
  • missing activity 2014
  • missing activity 2014
  • missing activity 2014
  • GHS604 - Infect Diseas of Glb Hlth Sign (Spring Term 2014) 2014
  • EPI697 - Internship (Fall Term 2013) 2013
  • EPI798 - Doctoral Directed Research (Fall Term 2013) 2013
  • EPI799 - Dissertation Research (Fall Term 2013) 2013
  • missing activity 2013
  • missing activity 2013
  • missing activity 2013
  • missing activity 2013
  • EPI698 - Directed Research (Summer Term 2013) 2013
  • missing activity 2013
  • missing activity 2013
  • missing activity 2013
  • missing activity 2013
  • EPI698 - Directed Research (Spring Term 2013) 2013
  • GHS604 - Infect Diseas of Glb Hlth Sign (Spring Term 2013) 2013
  • missing activity 2012
  • missing activity 2012
  • missing activity 2012
  • EPI697 - Internship (Fall Term 2012) 2012
  • EPI793 - DrPH Practicum (Fall Term 2012) 2012
  • EPI798 - Doctoral Directed Research (Fall Term 2012) 2012
  • GHS609 - Environ Hlth Issue Res Lim Set (Fall Term 2012) 2012
  • GHS610 - Refugee Health (Fall Term 2012) 2012
  • missing activity 2012
  • GHS600 - Fundamentals of Global Health (Summer Term 2012) 2012
  • missing activity 2012
  • missing activity 2012
  • EPI798 - Doctoral Directed Research (Summer Term 2012) 2012
  • missing activity 2012
  • missing activity 2012
  • GHS604 - Infect Diseas of Glb Hlth Sign (Spring Term 2012) 2012
  • GHS618 - Glob Hlth: Prin & Prac II (Spring Term 2012) 2012
  • missing activity 2011
  • missing activity 2011
  • missing activity 2011
  • EPI798 - Doctoral Directed Research (Fall Term 2011) 2011
  • GHS609 - Environ Hlth Issue Res Lim Set (Fall Term 2011) 2011
  • GHS610 - Refugee Health (Fall Term 2011) 2011
  • GHS605 - Disabilities and Global Health (Summer Term 2011) 2011
  • missing activity 2011
  • EPI697 - Internship (Summer Term 2011) 2011
  • GHS600 - Fund Glbl Hlth Prog/Pol/Practi (Summer Term 2011) 2011
  • missing activity 2011
  • missing activity 2011
  • GHS604 - Infect Diseas of Glb Hlth Sign (Spring Term 2011) 2011
  • missing activity 2010
  • missing activity 2010
  • missing activity 2010
  • missing activity 2010
  • missing activity 2010
  • GHS606 - Crit Issues Globl MCH (Fall Term 2010) 2010
  • GHS610 - Refugee Health (Fall Term 2010) 2010
  • missing activity 2010
  • missing activity 2010
  • GHS600 - Fundamenatls of Glbl Hlth: (Summer Term 2010) 2010
  • missing activity 2010
  • EPI798 - Doctoral Directed Research (Summer Term 2010) 2010
  • EPI799 - Dissertation Research (Summer Term 2010) 2010
  • EPI650 - GLB PERS DIS PRV/CON (Summer Term 2010) 2010
  • missing activity 2010
  • EPI799 - Dissertation Research (Spring Term 2010) 2010
  • GHS618 - Glob Hlth: Prin & Prac II (Spring Term 2010) 2010
  • missing activity 2009
  • missing activity 2009
  • missing activity 2009
  • EPI604 - Infec Dis:Fld Stdy in Dev Cty (Summer Term 2009) 2009
  • EPI697 - Internship (Summer Term 2009) 2009
  • EPI650 - GLB PERS DIS PRV/CON (Summer Term 2009) 2009
  • Education And Training

  • Bachelor of Science or Mathematics in Biochemistry, University of Wisconsin System : Madison
  • Doctor of Medicine, University of Wisconsin System : Madison
  • Full Name

  • Craig Wilson
  • Blazerid

  • cwilson